Literature DB >> 21316551

[Toward personalized and integrated treatment of patients with COPD].

Julio Ancochea1, Teresa Gómez García, Javier de Miguel Díez.   

Abstract

The concept of chronic obstructive pulmonary disease (COPD) is broad and generic. In clinical practice and research, the definition of COPD is based on the extent of airflow obstruction measured through spirometry. However, it is currently known that this disease encompasses a complex variety of cellular, anatomical, functional and clinical manifestations that could allow distinct COPD phenotypes to be defined. Moreover, the severity of COPD depends not only on pulmonary function evaluated through spirometry but also on other variables such as clinical symptoms, exacerbations and the presence of complications and comorbidities, which contribute to distinguishing among the distinct phenotypes. Phenotypic heterogeneity may affect treatment response and the clinical course of the disease. COPD is, therefore, a complex entity requiring comprehensive and multidimensional evaluation to establish more personalized and integrated treatment.
Copyright © 2010 Sociedad Española de Neumología y Cirugía Torácica. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21316551     DOI: 10.1016/S0300-2896(10)70051-X

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  2 in total

Review 1.  The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*.

Authors:  Stefano Nardini; Isabella Annesi-Maesano; Mario Del Donno; Maurizio Delucchi; Germano Bettoncelli; Vincenzo Lamberti; Carlo Patera; Mario Polverino; Antonio Russo; Carlo Santoriello; Patrizio Soverina
Journal:  Multidiscip Respir Med       Date:  2014-09-03

2.  [Perceptions of patients and health professionals about the quality of care provided to chronic obstructive pulmonary disease patients].

Authors:  Elena Tambo-Lizalde; José Miguel Carrasco-Gimeno; Susana Mayoral-Blasco; María José Rabanaque-Hernández; José María Abad-Díez
Journal:  Aten Primaria       Date:  2015-05-19       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.